Reuven Avital - Net Worth and Insider Trading

Reuven Avital Net Worth

The estimated net worth of Reuven Avital is at least $14 dollars as of 2024-11-13. Reuven Avital is the Director of Navidea Biopharmaceuticals Inc and owns about 14,463 shares of Navidea Biopharmaceuticals Inc (NAVB) stock worth over $14. Details can be seen in Reuven Avital's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Reuven Avital has not made any transactions after 2010-03-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Reuven Avital

To

Reuven Avital Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Reuven Avital owns 1 companies in total, including Navidea Biopharmaceuticals Inc (NAVB) .

Click here to see the complete history of Reuven Avital’s form 4 insider trades.

Insider Ownership Summary of Reuven Avital

Ticker Comapny Transaction Date Type of Owner
NAVB Navidea Biopharmaceuticals Inc 2010-03-16 director

Reuven Avital Latest Holdings Summary

Reuven Avital currently owns a total of 1 stock. Reuven Avital owns 14,463 shares of Navidea Biopharmaceuticals Inc (NAVB) as of March 16, 2010, with a value of $14.

Latest Holdings of Reuven Avital

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NAVB Navidea Biopharmaceuticals Inc 2010-03-16 14,463 0.00 14

Holding Weightings of Reuven Avital


Reuven Avital Form 4 Trading Tracker

According to the SEC Form 4 filings, Reuven Avital has made a total of 0 transactions in Navidea Biopharmaceuticals Inc (NAVB) over the past 5 years. The most-recent trade in Navidea Biopharmaceuticals Inc is the acquisition of 500 shares on March 16, 2010, which cost Reuven Avital around $21,000.

Insider Trading History of Reuven Avital

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Reuven Avital Trading Performance

GuruFocus tracks the stock performance after each of Reuven Avital's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Reuven Avital is -22.34%. GuruFocus also compares Reuven Avital's trading performance to market benchmark return within the same time period. The performance of stocks bought by Reuven Avital within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Reuven Avital's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Reuven Avital

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -11.17 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -13.99 LIMIT LIMIT LIMIT LIMIT LIMIT

Reuven Avital Ownership Network

Ownership Network List of Reuven Avital

No Data

Ownership Network Relation of Reuven Avital

Insider Network Chart

Reuven Avital Owned Company Details

What does Navidea Biopharmaceuticals Inc do?

Who are the key executives at Navidea Biopharmaceuticals Inc?

Reuven Avital is the director of Navidea Biopharmaceuticals Inc. Other key executives at Navidea Biopharmaceuticals Inc include Chief Financial Officer Craig Dais , director & 10 percent owner Scott John K Jr. , and Chief Regulatory Officer Michel Mikhail .

Navidea Biopharmaceuticals Inc (NAVB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Navidea Biopharmaceuticals Inc (NAVB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Navidea Biopharmaceuticals Inc (NAVB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Navidea Biopharmaceuticals Inc (NAVB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Navidea Biopharmaceuticals Inc Insider Transactions

No Available Data

Reuven Avital Mailing Address

Above is the net worth, insider trading, and ownership report for Reuven Avital. You might contact Reuven Avital via mailing address: 425 Metro Place North, Ste 400, Dublin Oh 43017.